Normally, when the Fed starts loosening policy it does so amid clear-cut signs of economic weakness.Economyread more
Wall Street economists are anxiously awaiting Wednesday's FOMC meeting.Marketsread more
With bold and targeted steps, economists say, government can increase opportunity and incomes for many more people in ways that strengthen, not weaken, American capitalism.Politicsread more
CNBC's Jim Cramer connects the dots by reasoning that if the president were to act he would pick a replacement for Powell that would do his bidding.Economyread more
Shoppers are "very nuanced in their expectations," Ron Johnson, the former CEO of J.C. Penney and the former senior vice president of Apple's retail division, said at CNBC's...Evolveread more
We've been given plenty of reasons to quit Facebook, including a new report that alleges disgusting working conditions at a company, Cognizant, it uses to employ contractors....Technologyread more
This just might be Fed Chair Jerome Powell's toughest meeting yet, because whatever the outcome, odds are high that it will disappoint a large group.Market Insiderread more
More and more American firms are calling for the Trump administration to resolve its conflict with China.World Economyread more
Facebook is leading the FANG stocks this year, and Miller Tabak's Matt Maley foresees more upside.Trading Nationread more
All trains traveling in and out of New York Penn Station have been halted because of an Amtrak overhead wire issue, New Jersey Transit said Wednesday.Transportationread more
American Airlines is the first major U.S. airline to order Airbus' new long-range, single aisle aircraft.Paris Air Showread more
Medical marijuana has new competition, and it's fierce: Sales of recreational pot in Colorado are growing faster than sales of medical pot, even though medical marijuana is cheaper because of a lower tax rate.
That trend will continue, according to the most thorough analysis yet of the two, side-by-side legal markets.
GreenWave Advisors, which provides analysis for the cannabis industry, reports that medical marijuana sales growth in Colorado dipped in 2014, as did the number of new medical cardholders.
"We forecast the average patient count will continue to decline from approximately 114,000 in 2014 to 99,000 by 2020," GreenWave said. At the same time, GreenWave predicts that the recreational side will see compound annual growth of 20 percent, "with likely upside as the market expands into new jurisdictions."
Is the future of medical marijuana going up in smoke? GreenWave said current fundamentals indicate that eventually, there will be only one legal marijuana market—one that combines medical and recreational under one set of regulations and a single tax rate.
There's also a chance that medical pot will find ways to differentiate itself from the for-fun kind.
"We believe that the medicinal use market will recalibrate when the pipeline of new, more targeted medications become available and as the medical profession gains more comfort in 'pushing' a marijuana treatment rather than a patient having to 'pull' a prescription," writes GreenWave's Matthew Karnes.
Leslie Bocskor, managing partner of Electrum Partners, an incubator for legal cannabis start-ups, took that prediction about medical pot's future even further last week. He told a group in Las Vegas that one of marijuana's most promising future markets will take cannabis beyond easing problems to curing them. He said there will be markets for pharmaceutical and "nutraceutical" products—meaning supplements and the like. "There will even be a veterinary market," he said.
One problem for those who'd like to see a separate medical marijuana market is that cannabis remains a Class I drug, which means the federal government sees no health benefit to it. Jan Carlos Byl of pot-cultivation consulting firm MedCanna said he would like to see the drug given a less restrictive classification "sooner rather than later, because it opens up research."
Byl said that while many proponents claim there are elements in the cannabis plant that could be very helpful in terms of health, legally recategorizing marijuana "is a key element to being able to definitely, or at least with a higher degree of certainty, say, 'yes or no—this is hogwash or this is legitimate.'"
CORRECTION: This version corrected the description of GreenWave Advisors: It's provides analysis for the cannabis industry.